MEDIA

NeoVesicle technology-based refractory disease treatment development company ㅣNvienceㅣ

2025.04.29

링크

 

 

There are about 350 million people with incurable diseases around the world and about 8,000 kinds of incurable diseases!

Even at this moment, countless patients and their families who have no cure are suffering.


Now, we're working on research and development, struggling to walk down a path that no one here has ever gotten to

Introducing [Nvience], a company that develops NeoVesicle technology-based treatment for intractable diseases!! 


LabCloud Membership [Nvience] Meet Choi Ki-young and Kim Jang-il's interview now! 

Non-clinical CRO crowise@woojungbio.kr
031-280-5200

LAB CLOUD labcloud@woojungbio.kr
031-280-5316

E&C sjjo@woojungbio.kr
031-280-5280